HEM1 deficiency disrupts mTORC2 and F-actin control in inherited immunodysregulatory disease.
Document Type
Article
Publication Date
7-10-2020
Identifier
DOI: 10.1126/science.aay5663
Abstract
Immunodeficiency often coincides with hyperactive immune disorders such as autoimmunity, lymphoproliferation, or atopy, but this coincidence is rarely understood on a molecular level. We describe five patients from four families with immunodeficiency coupled with atopy, lymphoproliferation, and cytokine overproduction harboring mutations in NCKAP1L, which encodes the hematopoietic-specific HEM1 protein. These mutations cause the loss of the HEM1 protein and the WAVE regulatory complex (WRC) or disrupt binding to the WRC regulator, Arf1, thereby impairing actin polymerization, synapse formation, and immune cell migration. Diminished cortical actin networks caused by WRC loss led to uncontrolled cytokine release and immune hyperresponsiveness. HEM1 loss also blocked mechanistic target of rapamycin complex 2 (mTORC2)-dependent AKT phosphorylation, T cell proliferation, and selected effector functions, leading to immunodeficiency. Thus, the evolutionarily conserved HEM1 protein simultaneously regulates filamentous actin (F-actin) and mTORC2 signaling to achieve equipoise in immune responses.
Journal Title
Science
Volume
369
Issue
6500
First Page
202
Last Page
207
MeSH Keywords
ADP-Ribosylation Factor 1; Actins; CD4-Positive T-Lymphocytes; Cell Proliferation; Cytokines; Humans; Immunologic Deficiency Syndromes; Lymphoproliferative Disorders; Mechanistic Target of Rapamycin Complex 2; Membrane Proteins; Pedigree; Phosphorylation; Wiskott-Aldrich Syndrome Protein Family
Keywords
ADP-Ribosylation Factor 1; Actins; CD4-Positive T-Lymphocytes; Cell Proliferation; Cytokines; Humans; Immunologic Deficiency Syndromes; Lymphoproliferative Disorders; Mechanistic Target of Rapamycin Complex 2; Membrane Proteins; Pedigree; Phosphorylation; Wiskott-Aldrich Syndrome Protein Family
Recommended Citation
Cook SA, Comrie WA, Poli MC, et al. HEM1 deficiency disrupts mTORC2 and F-actin control in inherited immunodysregulatory disease. Science. 2020;369(6500):202-207. doi:10.1126/science.aay5663
Comments
Grant support